KROS

KEROS THERAPEUTICS INC

KROS·492327101·US·Common Stock·Healthcare - Biotechnology-Activist

KROS (KEROS THERAPEUTICS INC) is held by 85 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($29.9M), AQR CAPITAL MANAGEMENT LLC ($10.4M), VANGUARD CAPITAL MANAGEMENT LLC ($8.9M). Net institutional sentiment: Mixed.

85
Holders
(7 Elite)
$153.4M
Total Value
44% (93)
Consensus
41 buying - 52 selling
13F: Insider & Congress: Updated regularly
KROS

Smart Money Verdict

View all
Loading verdict
Held by 85 funds
7 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 20, 2026 · Activists Jul 29, 2026 · Congress none

InsiderLRLerner Lorena RaquelSell $37KAug 18, 2026
InsiderCECho EstherSell $46KAug 18, 2026
InsiderNWNewton Charles W.Sell $6KAug 18, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.8M(+15.9%)$29.9M0.0%-24.80%
33
Increased
967,859(+138.1%)$10.4M0.0%-8.07%
45
Increased
833,596(+0.3%)$8.9M0.0%-16.97%
28
Increased
700,427(+1.6%)$7.5M0.0%-15.64%
28
Decreased
652,635(-4.3%)$7M0.0%-17.01%
0
Increased
628,438(+312.2%)$6.7M0.0%-2.22%
44
Decreased
608,837(-16.0%)$6.5M0.0%-39.38%
0
Decreased
605,445(-14.3%)$6.5M0.0%-26.74%
0
Decreased
541,193(-3.7%)$5.8M0.0%-73.20%
0
Decreased
510,841(-25.0%)$5.5M0.0%-73.03%
0
Increased
460,541(+43.3%)$4.9M0.0%-23.54%
36
Decreased
396,098(-2.6%)$4.2M0.0%-44.51%
0
Decreased
359,086(-20.8%)$3.8M0.0%-39.99%
0
Decreased
267,460(-47.5%)$2.9M0.0%-1.88%
0
Decreased
247,756(-5.5%)$2.7M0.0%-12.93%
0
Decreased
246,649(-32.2%)$2.6M0.0%-39.89%
0
Decreased
233,175(-60.5%)$2.5M0.0%-42.42%
0
Increased
184,822(+73.0%)$2M0.0%-31.74%
39
Decreased
177,846(-20.8%)$1.9M0.0%-24.67%
0
Decreased
158,712(-11.8%)$1.7M0.0%-71.23%
0

Showing 1-20 of 97

1 / 5
KROSKROSKEROS THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used